ArticleJCO precision oncology2024

Beyond Clinical Trials: Understanding Neurotrophic Tropomyosin Receptor Kinase Inhibitor Challenges and Efficacy in Real-World Pediatric Oncology.

Carolina Sgarioni Camargo Vince et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.